Wolfe Research Maintains Outperform on Cushman & Wakefield, Lowers Price Target to $28
Wolfe Research analyst Andrew Rosivach maintains Cushman & Wakefield (NYSE:CWK) with a Outperform and lowers the price target from $44 to $28.
Cushman & Wakefield Acquires Grant Street Associates; Terms Not Disclosed
Cushman & Wakefield (NYSE:CWK), a leading global real estate services firm, has acquired Grant Street Associates, Inc. in Pittsburgh, Pennsylvania after an 18-year alliance.
Grant Street Associates has been
Raymond James Maintains Strong Buy on Cushman & Wakefield, Raises Price Target to $38
Raymond James analyst Patrick O'Shaughnessy maintains Cushman & Wakefield (NYSE:CWK) with a Strong Buy and raises the price target from $35 to $38.
Recap: Cushman & Wakefield Q4 Earnings
Cushman & Wakefield (NYSE:CWK) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Analyst Ratings For Cushman & Wakefield
Over the past 3 months, 4 analysts have published their opinion on Cushman & Wakefield (NYSE:CWK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Cushman & Wakefield Named IBD Stock Of The Day
https://www.investors.com/research/ibd-stock-of-the-day/cwk-stock-commercial-real-estate-play-near-buy-point-with-earnings-surging/
Cushman & Wakefield Reports Purchase Of North By Northwest Consulting, No Terms Disclosed
Cushman & Wakefield (NYSE:CWK) announced the firm has acquired substantially all of the assets of North by Northwest Consulting (NxNW), a valuation services firm led by Anthony Alderman and based in Hickory, North
Cushman & Wakefield Report Finalization Of $500M Strategic Investment In Greystone
Cushman & Wakefield (NYSE:CWK), a leading global real estate services firm, announced today that it finalized its strategic investment of $500 million in Greystone, a leading national commercial real estate finance
Morgan Stanley Maintains Overweight on Cushman & Wakefield, Raises Price Target to $23.75
Morgan Stanley analyst Vikram Malhorta maintains Cushman & Wakefield (NYSE:CWK) with a Overweight and raises the price target from $21.75 to $23.75.
Raymond James Upgrades Cushman & Wakefield to Strong Buy, Announces $31 Price Target
Raymond James analyst Patrick O'Shaughnessy upgrades Cushman & Wakefield (NYSE:CWK) from Outperform to Strong Buy and announces $31 price target.